The purpose of this study was to determine the extent of metastatic pe
lvic lymph nodes evident on bipedal lymphography in a group of patient
s under consideration for combined radiation therapy and chemotherapy
as definitive treatment for carcinoma of the anal canal. Lymphography
was attempted in 32 patients and successful bilateral cannulation and
opacification of nodes was achieved in 28 (88%). Seven patients had ly
mphographic evidence of external iliac node metastases (25%). When pat
ients were categorized according to the extent of clinically evident d
isease at presentation, 0/15 patients with T1/T2 tumours had positive
lymphograms whereas 7/13 patients with T3/T4 tumours and/or positive i
nguinal or peri-rectal nodes had positive lymphograms (Fisher's exact
test p = 0.0015). All patients with a positive lymphogram had undergon
e CT scanning of the pelvis and in only one patient was external iliac
node involvement detected. In none of these patients was visceral or
more extensive nodal metastases discovered. Subsequently, the external
iliac nodes with radiological evidence of metastases on lymphography
were included in the treatment volume taken to radical dosage. The pro
jected cause specific actuarial 5 year survival for this cohort of pat
ients is 86% (median follow-up 4 years). Since the prognosis for patie
nts who relapse in pelvic nodes is poor. bipedal lymphography is advoc
ated as a staging procedure in patients with advanced primary tumours
and in all patients with clinically positive inguinal or peri-rectal l
ymph nodes who are being considered for curative therapy.